US FDA Offers Faster Route To Market Than EMA: Details On All 108 Approvals

Comprehensive table comparing all the novel agents approved by either the US FDA or the European Commission over 2023 through April 2024.

US-EU_topography_2261234821
Are the US and EU closer than they appear on approvals? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Regional Comparisons

More from Pink Sheet